| scholarly article | Q13442814 |
| P50 | author | Peter Andersen | Q54029065 |
| P2093 | author name string | Karin Weldingh | |
| Sandra M Arend | |||
| Pernille Ravn | |||
| Eliane M S Leyten | |||
| Inger Brock | |||
| P2860 | cites work | Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection | Q28191366 |
| Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis | Q28487469 | ||
| A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) | Q28487601 | ||
| Comparative genomics of BCG vaccines by whole-genome DNA microarray | Q29618558 | ||
| Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays | Q30697305 | ||
| Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG | Q30916431 | ||
| A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents | Q33592488 | ||
| Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig | Q33757008 | ||
| Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis | Q33757412 | ||
| Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. | Q33998194 | ||
| Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle | Q33999132 | ||
| Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens | Q34003037 | ||
| Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides | Q34004667 | ||
| Specific immune-based diagnosis of tuberculosis | Q34048117 | ||
| Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells | Q34082942 | ||
| Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak | Q34189548 | ||
| Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. | Q34257884 | ||
| Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence | Q34467579 | ||
| Specific Delayed-Type Hypersensitivity Responses to ESAT-6 Identify Tuberculosis-Infected Cattle | Q34991363 | ||
| Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis | Q35603209 | ||
| Rapid diagnosis of tuberculosis: laboratory techniques applicable in developing countries | Q35828858 | ||
| PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family | Q36375072 | ||
| Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis | Q36960119 | ||
| Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area | Q39250363 | ||
| An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. | Q39337020 | ||
| Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. | Q39506774 | ||
| Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle | Q39848660 | ||
| Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. | Q40160824 | ||
| Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. | Q40196856 | ||
| Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis | Q40587417 | ||
| Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis | Q40614563 | ||
| The tuberculin skin test | Q40716380 | ||
| Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. | Q40825071 | ||
| Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. | Q43939906 | ||
| Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. | Q48074697 | ||
| Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. | Q50689245 | ||
| Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. | Q51026150 | ||
| Use of ESAT‐6 and CFP‐10 Antigens for Diagnosis of Extrapulmonary Tuberculosis | Q58827865 | ||
| Detection of Active Tuberculosis Infection by T Cell Responses to Early‐Secreted Antigenic Target 6‐kDa Protein and Culture Filtrate Protein 10 | Q58827877 | ||
| The participation of common and species-"specific" antigens of Mycobacteria in the tuberculin skin reaction | Q67510328 | ||
| Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis | Q69770324 | ||
| Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis | Q70165040 | ||
| Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention | Q72990292 | ||
| Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells | Q73702459 | ||
| Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10 | Q73834329 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 2379-2387 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection | |
| P478 | volume | 42 |
| Q42671087 | A Proteome-Scale Identification of Novel Antigenic Proteins inMycobacterium tuberculosistoward Diagnostic and Vaccine Development |
| Q36431881 | An analysis of the epitope knowledge related to Mycobacteria |
| Q38213801 | Antigens for CD4 and CD8 T cells in tuberculosis |
| Q34586710 | Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource |
| Q37755029 | Biomarkers of latent TB infection |
| Q36422589 | Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis |
| Q44478347 | Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection |
| Q38940837 | Designing and Construction Pcdna3.1 Vector Encoding Cfp10 Gene of Mycobacterium tuberculosis |
| Q22241488 | Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? |
| Q42014010 | Diagnosis of latent tuberculosis: Can we do better? |
| Q37855146 | Diagnosis of tuberculosis infection using interferon-γ-based assays |
| Q42413222 | Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation |
| Q35936117 | Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ) |
| Q44484937 | Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis |
| Q40185882 | Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark |
| Q37137247 | Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan |
| Q46004722 | Evaluation of an Interferon Gamma Release Assay to Detect Tuberculosis Infection in Children in San Diego, California. |
| Q33496134 | Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers |
| Q28750995 | First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent |
| Q37451239 | Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections. |
| Q41616331 | Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells |
| Q38083313 | IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers |
| Q33767082 | IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. |
| Q58924849 | IFN-γ-release assays to diagnose TB infection in the immunocompromised individual |
| Q38909633 | Identification of Mycobacterium tuberculosis PPE68-specific HLA-A*0201-restricted epitopes for tuberculosis diagnosis |
| Q34738932 | Identification, diagnostic potential, and natural expression of immunodominant seroreactive peptides encoded by five Mycobacterium tuberculosis-specific genomic regions |
| Q54242408 | Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes. |
| Q37704867 | Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients. |
| Q34949342 | Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assay |
| Q35605635 | Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists |
| Q35965052 | Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. |
| Q36843374 | Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients |
| Q58924832 | Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment |
| Q37741088 | Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. |
| Q30425877 | Malnutrition and helminth infection affect performance of an interferon gamma-release assay |
| Q36504784 | Mycobacterium tuberculosis region of difference (RD) 2 antigen Rv1985c and RD11 antigen Rv3425 have the promising potential to distinguish patients with active tuberculosis from M. bovis BCG-vaccinated individuals |
| Q57100109 | Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen |
| Q28740799 | Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression |
| Q36564193 | Population tailored modification of tuberculosis specific interferon-gamma release assay |
| Q34034065 | Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection |
| Q36329910 | Prospects for a novel vaccine against tuberculosis |
| Q33468422 | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose |
| Q81225448 | Protective efficacy of BCG |
| Q35018134 | Recent Advances in Defining the Immunoproteome of Mycobacterium tuberculosis |
| Q30686035 | Review of the diagnosis of tuberculosis in non-bovid wildlife species using immunological methods--an update of published work since 2009. |
| Q58924859 | Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents |
| Q33694852 | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| Q37239545 | Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial |
| Q58924838 | Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy |
| Q22241138 | Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update |
| Q36470057 | TB vaccine strategies--what is needed to solve a complex problem? |
| Q89759520 | TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis |
| Q30360726 | The TB pandemic: an old problem seeking new solutions. |
| Q37025652 | The role of flow cytometry in the interferon-gamma-based diagnosis of active tuberculosis and its coinfection with HIV-1--A technically oriented review |
| Q37298854 | Tumour necrosis factor antagonists: structure, function, and tuberculosis risks |
| Q33936808 | Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. |
| Q41988978 | Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure |
| Q36452353 | Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. |
| Q46159067 | Weakly positive tests and chronologic variation of the QuantiFERON assay: a retrospective appraisal of usefulness |
| Q31156691 | Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses |
| Q80237437 | [New blood tests for diagnosis of infection with Mycobacterium tuberculosis] |
| Q53800517 | [New immunological tests in the diagnosis of tuberculosis] |
Search more.